Holger Petersen

Person

Eimeldingen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Sustained release formulation comprising octreotide and three linea...
- Patent number 8,999,390
- Issue date Apr 7, 2015
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-...
- Patent number 8,487,095
- Issue date Jul 16, 2013
- Novartis AG
- Martin James Drysdale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-...
- Patent number 8,163,747
- Issue date Apr 24, 2012
- Novartis AG
- Martin James Drysdale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Octreotide Depot Formulation with Constantly High Exposure Levels
- Publication number 20250205147
- Publication date Jun 26, 2025
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...
- Publication number 20250082718
- Publication date Mar 13, 2025
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octreotide Depot Formulation with Constantly High Exposure Levels
- Publication number 20240082148
- Publication date Mar 14, 2024
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...
- Publication number 20220296675
- Publication date Sep 22, 2022
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20220273574
- Publication date Sep 1, 2022
- Novartis AG
- Holger PETERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octreotide Depot Formulation with Constantly High Exposure Levels
- Publication number 20210161806
- Publication date Jun 3, 2021
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...
- Publication number 20200206306
- Publication date Jul 2, 2020
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20200009056
- Publication date Jan 9, 2020
- Novartis AG
- Holger PETERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octreotide depot formulation with constantly high exposure levels
- Publication number 20190209462
- Publication date Jul 11, 2019
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained Release Formulation Comprising Octreotide and Two or More...
- Publication number 20180140662
- Publication date May 24, 2018
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
- Publication number 20180036230
- Publication date Feb 8, 2018
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Organic Compounds
- Publication number 20170281548
- Publication date Oct 5, 2017
- Novartis AG
- Holger PETERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
- Publication number 20170143791
- Publication date May 25, 2017
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustanined Release Formulation Comprising Octreotide and Two or Mor...
- Publication number 20160120935
- Publication date May 5, 2016
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octreotide depot formulation with constantly high exposure levels
- Publication number 20160089336
- Publication date Mar 31, 2016
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained Release Formulation Comprising Octreotide and Two or More...
- Publication number 20150037420
- Publication date Feb 5, 2015
- Novartis AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octreotide Depot Formulation with Constantly High Exposure Levels
- Publication number 20140363513
- Publication date Dec 11, 2014
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORGANIC COMPOUNDS
- Publication number 20140323415
- Publication date Oct 30, 2014
- Holger PETERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-...
- Publication number 20130296556
- Publication date Nov 7, 2013
- Novartis AG
- Martin James Drysdale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEA...
- Publication number 20120226224
- Publication date Sep 6, 2012
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5-(2,4-DIHYDROXY-5-...
- Publication number 20120172592
- Publication date Jul 5, 2012
- Martin James Drysdale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octreotide depot formulation with constantly high exposure levels
- Publication number 20110262545
- Publication date Oct 27, 2011
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEA...
- Publication number 20110003002
- Publication date Jan 6, 2011
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
- Publication number 20100266704
- Publication date Oct 21, 2010
- Novartis AG
- Markus Ahlheim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-...
- Publication number 20100093732
- Publication date Apr 15, 2010
- Martin James Drysdale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF ZOLEDRONIC ACID
- Publication number 20100056481
- Publication date Mar 4, 2010
- Alexandra Glausch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPONATES
- Publication number 20100047306
- Publication date Feb 25, 2010
- Novartis AG
- Rolf Loeffler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained Release Formulation Comprising Octreotide and Two or More...
- Publication number 20090004283
- Publication date Jan 1, 2009
- Nivartus AG
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Organic compounds
- Publication number 20070122485
- Publication date May 31, 2007
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Organic compounds
- Publication number 20040097419
- Publication date May 20, 2004
- Holger Petersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Holger Petersen

Person

Patents Grantslast 30 patents

Sustained release formulation comprising octreotide and three linea...

Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-...

Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-...

Patents Applicationslast 30 patents

Octreotide Depot Formulation with Constantly High Exposure Levels

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...

Octreotide Depot Formulation with Constantly High Exposure Levels

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...

ORGANIC COMPOUNDS

Octreotide Depot Formulation with Constantly High Exposure Levels

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE...

ORGANIC COMPOUNDS

Octreotide depot formulation with constantly high exposure levels

Sustained Release Formulation Comprising Octreotide and Two or More...

OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS

Organic Compounds

OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS

Sustanined Release Formulation Comprising Octreotide and Two or Mor...

Octreotide depot formulation with constantly high exposure levels

Sustained Release Formulation Comprising Octreotide and Two or More...

Octreotide Depot Formulation with Constantly High Exposure Levels

ORGANIC COMPOUNDS

Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-...

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEA...

ACID ADDITION SALTS, HYDRATES AND POLYMORPHS OF 5-(2,4-DIHYDROXY-5-...

Octreotide depot formulation with constantly high exposure levels

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEA...

OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS

Acid Addition Salts, Hydrates and Polymorphs of 5-(2,4-Dihydroxy-5-...

CRYSTALLINE FORMS OF ZOLEDRONIC ACID

PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPONATES

Sustained Release Formulation Comprising Octreotide and Two or More...

Organic compounds

Organic compounds